Comparing strong vs very strong cholesterol drugs after a heart attack
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests whether adding two extra medicines to a common cholesterol-lowering statin lowers LDL ('bad') cholesterol more effectively in people recently hospitalized for a heart attack or unstable chest pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have had a heart attack or unstable chest pain that required a hospital stay.
- You must be able to take a strong statin medicine like atorvastatin.
- You agree to take the study drugs and come for follow-up visits.
- You do not have serious liver or kidney problems, frequent gout attacks, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to check heart risk and start treatment for cholesterol in people coming to the emergency room with chest pain or possible heart attack. It aims to see if early risk assessment and treatment can prevent future heart problems.
This trial tests a triple therapy pill (bempedoic acid, ezetimibe, and a high-intensity statin) in patients who have extensive plaque in their heart arteries but have never had a heart attack or stroke. It aims to see if this combination can further lower cholesterol and prevent future problems.
This trial tests whether taking a moderate-strength statin (cholesterol-lowering drug) plus ezetimibe (another cholesterol medicine) together helps protect the heart and kidneys in people who have both chronic kidney disease and established heart disease or stroke history.
This study compares two cholesterol treatment approaches after a heart attack: a lower dose combination versus a higher dose single medicine. It aims to see which option works well and is tolerable for people after a treated heart attack.
This trial studies how well long-term cholesterol-lowering treatment works in people who recently had a heart attack (STEMI or NSTEMI). It may help your care team understand which patients benefit most and how treatment should be continued safely.
This trial looks at when and how to use cholesterol-lowering treatment soon after a heart attack. It may help people lower LDL (“bad” cholesterol) safely in the first days after an acute event.
Hear when a new Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.